{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:18:38Z","timestamp":1792757918501,"version":"4.5.0"},"reference-count":224,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008097","name":"Edward N and Della L Thome Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007457","name":"JPB Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003239","name":"Robert J and Claire Pasarow Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003239","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bcp.2024.116174","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T13:29:02Z","timestamp":1711546142000},"page":"116174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke"],"prefix":"10.1016","volume":"228","author":[{"given":"Liu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Guttman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valina L.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2024.116174_b0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bph.13748","article-title":"Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases","volume":"175","author":"Berger","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12964-021-00799-8","article-title":"Regulated cell death: discovery, features and implications for neurodegenerative diseases","volume":"19","author":"Cui","year":"2021","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2024.116174_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.662034","article-title":"Targeting Parthanatos in ischemic stroke","volume":"12","author":"Koehler","year":"2021","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.bcp.2024.116174_b0020","doi-asserted-by":"crossref","first-page":"e1044","DOI":"10.1002\/ctm2.1044","article-title":"Pharmacologic inhibition of MIF nuclease: a new treatment paradigm to treat cell death","volume":"12","author":"Biswas","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"3","key":"10.1016\/j.bcp.2024.116174_b0025","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2741\/3297","article-title":"Parthanatos, a messenger of death","volume":"14","author":"David","year":"2009","journal-title":"Front Biosci (landmark Ed)"},{"issue":"8","key":"10.1016\/j.bcp.2024.116174_b0030","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/bph.12416","article-title":"Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities","volume":"171","author":"Fatokun","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116174_b0035","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev-pharmtox-010716-105001","article-title":"Mitochondrial mechanisms of neuronal cell death: potential therapeutics","volume":"57","author":"Dawson","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116174_b0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1083\/jcb.200202130","article-title":"Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death","volume":"158","author":"Cregan","year":"2002","journal-title":"J. Cell Biol."},{"issue":"16","key":"10.1016\/j.bcp.2024.116174_b0045","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1038\/sj.onc.1207517","article-title":"Role of AIF in caspase-dependent and caspase-independent cell death","volume":"23","author":"Cregan","year":"2004","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.bcp.2024.116174_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137292","article-title":"Molecular mechanisms of Parthanatos and its role in diverse diseases","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2024.116174_b0055","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.molcel.2018.07.002","article-title":"Poly(ADP-Ribose) Prevents pathological phase Separation of TDP-43 by promoting liquid demixing and stress granule localization","volume":"71","author":"McGurk","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2024.116174_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ircmb.2019.12.009","article-title":"Poly (ADP-ribose) (PAR)-dependent cell death in neurodegenerative diseases","volume":"353","author":"Park","year":"2020","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116174_b0065","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molcel.2006.12.012","article-title":"DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation","volume":"25","author":"Cohen-Armon","year":"2007","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.bcp.2024.116174_b0070","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nn.3500","article-title":"Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss","volume":"16","author":"Lee","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.bcp.2024.116174_b0075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nm.2387","article-title":"Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death","volume":"17","author":"Andrabi","year":"2011","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bcp.2024.116174_b0080","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.mp.4000272","article-title":"Nitric oxide in health and disease of the nervous system","volume":"2","author":"Yun","year":"1997","journal-title":"Mol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.bcp.2024.116174_b0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2012.10.032","article-title":"Excitotoxicity: bridge to various triggers in neurodegenerative disorders","volume":"698","author":"Mehta","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"21","key":"10.1016\/j.bcp.2024.116174_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21217997","article-title":"Coordination between calcium\/calmodulin-dependent protein kinase II and neuronal nitric oxide synthase in neurons","volume":"21","author":"Araki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116174_b0095","doi-asserted-by":"crossref","unstructured":"Y. Xia, V.L. Dawson, T.M. Dawson, S.H. Snyder, J.L. Zweier, Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury, Proceedings of the National Academy of Sciences of the United States of America 93(13) (1996) 6770-4.","DOI":"10.1073\/pnas.93.13.6770"},{"issue":"9","key":"10.1016\/j.bcp.2024.116174_b0100","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/carcin\/16.9.2045","article-title":"Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro","volume":"16","author":"Yermilov","year":"1995","journal-title":"Carcinogenesis"},{"issue":"21","key":"10.1016\/j.bcp.2024.116174_b0105","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1093\/nar\/24.21.4105","article-title":"DNA damage by peroxynitrite characterized with DNA repair enzymes","volume":"24","author":"Epe","year":"1996","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.bcp.2024.116174_b0110","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"Forstermann","year":"2012","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.bcp.2024.116174_b0115","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s12291-014-0475-8","article-title":"Pathophysiological role of peroxynitrite induced DNA damage in human diseases: a special focus on Poly(ADP-ribose) Polymerase (PARP), indian","volume":"30","author":"Islam","year":"2015","journal-title":"J Clin Biochem"},{"key":"10.1016\/j.bcp.2024.116174_b0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/bs.apha.2017.09.003","article-title":"Nitric oxide signaling in neurodegeneration and cell death","volume":"82","author":"Dawson","year":"2018","journal-title":"Adv. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116174_b0125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0968-0004(94)90280-1","article-title":"Poly(ADP-ribose) polymerase: a molecular nick-sensor","volume":"19","author":"de Murcia","year":"1994","journal-title":"Trends Biochem. Sci"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2024.116174_b0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00928438","article-title":"Structure and function of poly(ADP-ribose) polymerase","volume":"138","author":"de Murcia","year":"1994","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.bcp.2024.116174_b0135","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1471-4159.2010.06667.x","article-title":"Contributions of poly(ADP-ribose) polymerase-1 and -2 to nuclear translocation of apoptosis-inducing factor and injury from focal cerebral ischemia","volume":"113","author":"Li","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2024.116174_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2021.103125","article-title":"PARP1: structural insights and pharmacological targets for inhibition","volume":"103","author":"Spiegel","year":"2021","journal-title":"DNA Repair (amst)"},{"key":"10.1016\/j.bcp.2024.116174_b0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2142\/biophysico.16.0_59","article-title":"Single-particle analysis of full-length human poly(ADP-ribose) polymerase 1","volume":"16","author":"Kouyama","year":"2019","journal-title":"Biophys Physicobiol"},{"key":"10.1016\/j.bcp.2024.116174_b0150","doi-asserted-by":"crossref","unstructured":"S.A. Andrabi, N.S. Kim, S.W. Yu, H. Wang, D.W. Koh, M. Sasaki, J.A. Klaus, T. Otsuka, Z. Zhang, R.C. Koehler, P.D. Hurn, G.G. Poirier, V.L. Dawson, T.M. Dawson, Poly(ADP-ribose) (PAR) polymer is a death signal, Proceedings of the National Academy of Sciences of the United States of America 103(48) (2006) 18308-13.","DOI":"10.1073\/pnas.0606526103"},{"key":"10.1016\/j.bcp.2024.116174_b0155","doi-asserted-by":"crossref","unstructured":"H.C. Kang, Y.I. Lee, J.H. Shin, S.A. Andrabi, Z. Chi, J.P. Gagne, Y. Lee, H.S. Ko, B.D. Lee, G.G. Poirier, V.L. Dawson, T.M. Dawson, Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage, Proceedings of the National Academy of Sciences of the United States of America 108(34) (2011) 14103-8.","DOI":"10.1073\/pnas.1108799108"},{"issue":"5","key":"10.1016\/j.bcp.2024.116174_b0160","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ncb2222","article-title":"RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and wnt signalling","volume":"13","author":"Zhang","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116174_b0165","doi-asserted-by":"crossref","unstructured":"J. Fan, B.G. Kang, T.-I. Kam, A.A. Behensky, J. Rines, H.C. Kang, V.L. Dawson, T.M. Dawson, Histone H1.2 Dependent Translocation of Poly (ADP-ribose) Initiates Parthanatos, bioRxiv (2023) 2023.06.18.545460.","DOI":"10.1101\/2023.06.18.545460"},{"issue":"7","key":"10.1016\/j.bcp.2024.116174_b0170","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41422-018-0048-0","article-title":"Destabilization of linker histone H1.2 is essential for ATM activation and DNA damage repair","volume":"28","author":"Li","year":"2018","journal-title":"Cell Res."},{"issue":"7","key":"10.1016\/j.bcp.2024.116174_b0175","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.molcel.2022.02.028","article-title":"Hexokinase 1 cellular localization regulates the metabolic fate of glucose","volume":"82","author":"De Jesus","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2024.116174_b0180","doi-asserted-by":"crossref","unstructured":"S.A. Andrabi, G.K. Umanah, C. Chang, D.A. Stevens, S.S. Karuppagounder, J.P. Gagne, G.G. Poirier, V.L. Dawson, T.M. Dawson, Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis, Proceedings of the National Academy of Sciences of the United States of America 111(28) (2014) 10209-14.","DOI":"10.1073\/pnas.1405158111"},{"issue":"6","key":"10.1016\/j.bcp.2024.116174_b0185","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.celrep.2014.08.036","article-title":"ARTD1\/PARP1 negatively regulates glycolysis by inhibiting hexokinase 1 independent of NAD+ depletion","volume":"8","author":"Fouquerel","year":"2014","journal-title":"Cell Rep."},{"issue":"167","key":"10.1016\/j.bcp.2024.116174_b0190","doi-asserted-by":"crossref","first-page":"ra20","DOI":"10.1126\/scisignal.2000902","article-title":"Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos","volume":"4","author":"Wang","year":"2011","journal-title":"Sci. Signal."},{"issue":"2","key":"10.1016\/j.bcp.2024.116174_b0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0092-8674(02)01046-2","article-title":"Dueling activities of AIF in cell death versus survival: DNA binding and redox activity","volume":"111","author":"Lipton","year":"2002","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bcp.2024.116174_b0200","doi-asserted-by":"crossref","DOI":"10.1042\/AN20090046","article-title":"Outer mitochondrial membrane localization of apoptosis-inducing factor: mechanistic implications for release","volume":"1","author":"Yu","year":"2009","journal-title":"ASN Neuro"},{"key":"10.1016\/j.bcp.2024.116174_b0205","doi-asserted-by":"crossref","unstructured":"S.W. Yu, S.A. Andrabi, H. Wang, N.S. Kim, G.G. Poirier, T.M. Dawson, V.L. Dawson, Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death, Proceedings of the National Academy of Sciences of the United States of America 103(48) (2006) 18314-9.","DOI":"10.1073\/pnas.0606528103"},{"key":"10.1016\/j.bcp.2024.116174_b0210","doi-asserted-by":"crossref","unstructured":"H. Park, T.I. Kam, H. Peng, S.C. Chou, A.A. Mehrabani-Tabari, J.J. Song, X. Yin, S.S. Karuppagounder, G.K. Umanah, A.V.S. Rao, Y. Choi, A. Aggarwal, S. Chang, H. Kim, J. Byun, J.O. Liu, T.M. Dawson, V.L. Dawson, PAAN\/MIF nuclease inhibition prevents neurodegeneration in Parkinson's disease, Cell 185(11) (2022) 1943-1959 e21.","DOI":"10.1016\/j.cell.2022.04.020"},{"issue":"6308","key":"10.1016\/j.bcp.2024.116174_b0215","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad6872","article-title":"A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1","volume":"354","author":"Wang","year":"2016","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bcp.2024.116174_b0220","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41419-022-04918-2","article-title":"Macrophage migration inhibitory factor (MIF) acetylation protects neurons from ischemic injury","volume":"13","author":"Hu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bcp.2024.116174_b0225","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","article-title":"Role of neuroinflammation in neurodegenerative diseases (review)","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"11","key":"10.1016\/j.bcp.2024.116174_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0235","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0245","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1038\/s41467-021-26519-x","article-title":"Microglia-specific overexpression of alpha-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity","volume":"12","author":"Bido","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2024.116174_b0250","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in parkinson's disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2024.116174_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in parkinson's disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0260","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl Neurodegener"},{"issue":"9","key":"10.1016\/j.bcp.2024.116174_b0265","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.it.2016.06.006","article-title":"Astrocytes: key regulators of neuroinflammation","volume":"37","author":"Colombo","year":"2016","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116174_b0270","doi-asserted-by":"crossref","first-page":"664","DOI":"10.14336\/AD.2018.0720","article-title":"Reactive astrocytes in neurodegenerative diseases","volume":"10","author":"Li","year":"2019","journal-title":"Aging Dis."},{"issue":"7883","key":"10.1016\/j.bcp.2024.116174_b0275","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-021-03960-y","article-title":"Neurotoxic reactive astrocytes induce cell death via saturated lipids","volume":"599","author":"Guttenplan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116174_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106314","article-title":"Poly (ADP-ribose) polymerase 1 and parthanatos in neurological diseases: from pathogenesis to therapeutic opportunities","volume":"187","author":"Xu","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2024.116174_b0285","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuint.2017.04.014","article-title":"Poly(ADP-ribose) polymerase-1 regulates microglia mediated decrease of endothelial tight junction integrity","volume":"108","author":"Mehrabadi","year":"2017","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.bcp.2024.116174_b0290","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/brb3.239","article-title":"PARP1 enhances inflammatory cytokine expression by alteration of promoter chromatin structure in microglia","volume":"4","author":"Martinez-Zamudio","year":"2014","journal-title":"Brain Behav."},{"issue":"8","key":"10.1016\/j.bcp.2024.116174_b0295","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1089\/neu.2013.3194","article-title":"PARP-1 inhibition attenuates neuronal loss, microglia activation and neurological deficits after traumatic brain injury","volume":"31","author":"Stoica","year":"2014","journal-title":"J. Neurotrauma"},{"issue":"7","key":"10.1016\/j.bcp.2024.116174_b0300","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1089\/neu.2017.5044","article-title":"Effects of Veliparib on microglial activation and functional outcomes after traumatic brain injury in the rat and pig","volume":"35","author":"Irvine","year":"2018","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2024.116174_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116174_b0310","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/s41401-022-00879-6","article-title":"Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases","volume":"43","author":"Lin","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.bcp.2024.116174_b0315","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.bcp.2024.116174_b0320","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/glia.24260","article-title":"Microglial AIM2 alleviates antiviral-related neuro-inflammation in mouse models of Parkinson's disease","volume":"70","author":"Rui","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2024.116174_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101202","article-title":"Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases","volume":"65","author":"Wu","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"6414","key":"10.1016\/j.bcp.2024.116174_b0330","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8407","article-title":"Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson's disease","volume":"362","author":"Kam","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bcp.2024.116174_b0335","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2019.07.018","article-title":"A.s. group, multicenter Alzheimer's and Parkinson's disease immune biomarker verification study","volume":"16","author":"Brosseron","year":"2020","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0340","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12974-023-02993-6","article-title":"MIF contribution to progressive brain diseases","volume":"21","author":"Matejuk","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0345","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s10020-020-00163-5","article-title":"Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer's disease","volume":"26","author":"Nasiri","year":"2020","journal-title":"Mol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2024.116174_b0350","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"7722","key":"10.1016\/j.bcp.2024.116174_b0355","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41586-018-0448-9","article-title":"Parkin and PINK1 mitigate STING-induced inflammation","volume":"561","author":"Sliter","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116174_b0360","doi-asserted-by":"crossref","unstructured":"J.T. Hinkle, J. Patel, N. Panicker, S.S. Karuppagounder, D. Biswas, B. Belingon, R. Chen, S. Brahmachari, O. Pletnikova, J.C. Troncoso, V.L. Dawson, T.M. Dawson, STING mediates neurodegeneration and neuroinflammation in nigrostriatal alpha-synucleinopathy, Proceedings of the National Academy of Sciences of the United States of America 119(15) (2022) e2118819119.","DOI":"10.1073\/pnas.2118819119"},{"issue":"7265","key":"10.1016\/j.bcp.2024.116174_b0365","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity","volume":"461","author":"Ishikawa","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116174_b0370","doi-asserted-by":"crossref","first-page":"17023-","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1016\/j.bcp.2024.116174_b0375","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","article-title":"MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration","volume":"26","author":"Lee","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2024.116174_b0380","doi-asserted-by":"crossref","unstructured":"N. Panicker, T.I. Kam, H. Wang, S. Neifert, S.C. Chou, M. Kumar, S. Brahmachari, A. Jhaldiyal, J.T. Hinkle, F. Akkentli, X. Mao, E. Xu, S.S. Karuppagounder, E.T. Hsu, S.U. Kang, O. Pletnikova, J. Troncoso, V.L. Dawson, T.M. Dawson, Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease, Neuron 110(15) (2022) 2422-2437 e9.","DOI":"10.1016\/j.neuron.2022.05.009"},{"issue":"7237","key":"10.1016\/j.bcp.2024.116174_b0385","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature07710","article-title":"AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA","volume":"458","author":"Fernandes-Alnemri","year":"2009","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2024.116174_b0390","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/jnc.13217","article-title":"The pathogenic role of the inflammasome in neurodegenerative diseases","volume":"136","author":"Freeman","year":"2016","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.bcp.2024.116174_b0395","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.tins.2023.07.009","article-title":"Inflammasome assembly in neurodegenerative diseases","volume":"46","author":"Singh","year":"2023","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0400","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/s41467-018-04581-2","article-title":"Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation","volume":"9","author":"Lang","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0405","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.bcp.2024.116174_b0410","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/pharmrev.120.000189","article-title":"Parkinson disease: translating insights from Molecular mechanisms to neuroprotection","volume":"73","author":"Pirooznia","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2024.116174_b0415","unstructured":"P.s. Foundation, Who has Parkinson\u2019s? . https:\/\/www.parkinson.org\/understanding-parkinsons\/statistics."},{"key":"10.1016\/j.bcp.2024.116174_b0420","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.bcp.2024.116174_b0425","first-page":"e13275","article-title":"Spectrum of non-motor symptoms in Parkinson's disease","volume":"13","author":"Kumaresan","year":"2021","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.bcp.2024.116174_b0430","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2024.116174_b0435","doi-asserted-by":"crossref","first-page":"fcac042","DOI":"10.1093\/braincomms\/fcac042","article-title":"Evaluation of ABT-888 in the amelioration of alpha-synuclein fibril-induced neurodegeneration","volume":"4","author":"Hastings","year":"2022","journal-title":"Brain Commun"},{"issue":"6","key":"10.1016\/j.bcp.2024.116174_b0440","doi-asserted-by":"crossref","first-page":"e13163","DOI":"10.1111\/acel.13163","article-title":"Poly (ADP-ribose) polymerase 1 inhibition prevents neurodegeneration and promotes alpha-synuclein degradation via transcription factor EB-dependent autophagy in mutant alpha-synucleinA53T model of Parkinson's disease","volume":"19","author":"Mao","year":"2020","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.bcp.2024.116174_b0445","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.bbrc.2007.03.163","article-title":"Pharmacological inhibition of PARP-1 reduces alpha-synuclein- and MPP+-induced cytotoxicity in Parkinson's disease in vitro models","volume":"357","author":"Outeiro","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.bcp.2024.116174_b0450","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102111","article-title":"PARP1 in Carcinomas and PARP1 inhibitors as antineoplastic drugs","volume":"18","author":"Wang","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.bcp.2024.116174_b0455","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrm.2017.53","article-title":"The multifaceted roles of PARP1 in DNA repair and chromatin remodelling","volume":"18","author":"Ray Chaudhuri","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116174_b0460","unstructured":"N.I.o. Aging, Alzheimer's Disease Fact Sheet. https:\/\/www.nia.nih.gov\/health\/alzheimers-and-dementia\/alzheimers-disease-fact-sheet."},{"key":"10.1016\/j.bcp.2024.116174_b0465","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.937133","article-title":"Neuronal cell death mechanisms in Alzheimer's disease: an insight","volume":"15","author":"Goel","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2024.116174_b0470","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer's disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116174_b0475","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-beta pathway in Alzheimer's disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.bcp.2024.116174_b0480","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s12264-022-00985-9","article-title":"Physiological roles of beta-amyloid in regulating synaptic function: implications for AD pathophysiology","volume":"39","author":"Cai","year":"2023","journal-title":"Neurosci. Bull."},{"issue":"2","key":"10.1016\/j.bcp.2024.116174_b0485","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nn.3606","article-title":"Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease","volume":"17","author":"Khan","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bcp.2024.116174_b0490","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnins.2019.00043","article-title":"The role of NMDA receptors in Alzheimer's disease","volume":"13","author":"Liu","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.bcp.2024.116174_b0495","doi-asserted-by":"crossref","first-page":"17842","DOI":"10.1038\/srep17842","article-title":"Reactivity of metal-free and metal-associated amyloid-beta with glycosylated polyphenols and their esterified derivatives","volume":"5","author":"Korshavn","year":"2015","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.bcp.2024.116174_b0500","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1021\/acschemneuro.3c00486","article-title":"Oxidative stress occurs prior to amyloid abeta plaque formation and tau phosphorylation in Alzheimer's disease: role of glutathione and metal ions","volume":"14","author":"Roy","year":"2023","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.bcp.2024.116174_b0505","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/352723","article-title":"The ambiguous relationship of oxidative stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease","volume":"2015","author":"Liu","year":"2015","journal-title":"Oxid Med. Cell Longev"},{"key":"10.1016\/j.bcp.2024.116174_b0510","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fncel.2014.00084","article-title":"A major role for tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions","volume":"8","author":"Violet","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bcp.2024.116174_b0515","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainresbull.2016.06.005","article-title":"Oxidative stress, protein modification and Alzheimer disease","volume":"133","author":"Tramutola","year":"2017","journal-title":"Brain Res. Bull."},{"issue":"8","key":"10.1016\/j.bcp.2024.116174_b0520","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1111\/febs.15716","article-title":"The role of PARP1 in neurodegenerative diseases and aging","volume":"289","author":"Mao","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2024.116174_b0525","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fnagi.2020.00255","article-title":"Nicotinamide, a poly [ADP-ribose] Polymerase 1 (PARP-1) inhibitor, as an adjunctive therapy for the treatment of Alzheimer's disease","volume":"12","author":"Salech","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"9","key":"10.1016\/j.bcp.2024.116174_b0530","doi-asserted-by":"crossref","first-page":"e72169","DOI":"10.1371\/journal.pone.0072169","article-title":"PARP-1 modulates amyloid beta peptide-induced neuronal damage","volume":"8","author":"Martire","year":"2013","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.bcp.2024.116174_b0535","doi-asserted-by":"crossref","first-page":"9065","DOI":"10.1021\/acs.chemrev.2c00851","article-title":"Regulation of Biomolecular condensates by Poly(ADP-ribose)","volume":"123","author":"Rhine","year":"2023","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bcp.2024.116174_b0540","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2202-15-73","article-title":"The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not in the hippocampus in the TgCRND8 mouse model of Alzheimer's disease","volume":"15","author":"Yu","year":"2014","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0545","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13195-019-0508-x","article-title":"Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer's disease","volume":"11","author":"Zhang","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bcp.2024.116174_b0550","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1742-2094-8-152","article-title":"Poly(ADP-ribose)polymerase-1 modulates microglial responses to amyloid beta","volume":"8","author":"Kauppinen","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0555","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12035-012-8258-9","article-title":"Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer's disease","volume":"46","author":"Strosznajder","year":"2012","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116174_b0560","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41419-021-03926-y","article-title":"Parp mutations protect from mitochondrial toxicity in Alzheimer's disease","volume":"12","author":"Yu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2024.116174_b0565","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bcp.2019.04.028","article-title":"New insights of poly(ADP-ribosylation) in neurodegenerative diseases: a focus on protein phase separation and pathologic aggregation","volume":"167","author":"Liu","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116174_b0570","doi-asserted-by":"crossref","first-page":"17085","DOI":"10.1038\/nrdp.2017.85","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0575","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","article-title":"The role of TDP-43 mislocalization in amyotrophic lateral sclerosis","volume":"15","author":"Suk","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"9","key":"10.1016\/j.bcp.2024.116174_b0580","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","article-title":"C9orf72-mediated ALS and FTD: multiple pathways to disease","volume":"14","author":"Balendra","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bcp.2024.116174_b0585","doi-asserted-by":"crossref","first-page":"13416","DOI":"10.1038\/srep13416","article-title":"Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions","volume":"5","author":"Farrawell","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116174_b0590","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"Mechanisms, and therapeutics: where are we now?","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2024.116174_b0595","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1212\/01.WNL.0000103291.04985.DC","article-title":"Widespread increased expression of the DNA repair enzyme PARP in brain in ALS","volume":"62","author":"Kim","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0600","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40478-018-0586-1","article-title":"Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis","volume":"6","author":"McGurk","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"10.1016\/j.bcp.2024.116174_b0605","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neulet.2006.07.044","article-title":"AIF translocates to the nucleus in the spinal motor neurons in a mouse model of ALS","volume":"406","author":"Oh","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2024.116174_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105077","article-title":"PARP-1 activation leads to cytosolic accumulation of TDP-43 in neurons","volume":"148","author":"Marcus","year":"2021","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0615","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/nar\/gkt835","article-title":"PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS\/TLS to sites of oxidative DNA damage","volume":"42","author":"Rulten","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"662","key":"10.1016\/j.bcp.2024.116174_b0620","doi-asserted-by":"crossref","first-page":"eabq3215","DOI":"10.1126\/scitranslmed.abq3215","article-title":"Poly(ADP-ribose) promotes toxicity of C9ORF72 arginine-rich dipeptide repeat proteins","volume":"14","author":"Gao","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"19","key":"10.1016\/j.bcp.2024.116174_b0625","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1093\/hmg\/ddac116","article-title":"Genetic and pharmacological PARP inhibition reduces axonal degeneration in C. elegans models of ALS","volume":"31","author":"Tossing","year":"2022","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.bcp.2024.116174_b0630","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41422-019-0141-z","article-title":"PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins","volume":"29","author":"Duan","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2024.116174_b0635","unstructured":"H.s.D.S.o. America, WHO IS AT RISK? https:\/\/hdsa.org\/what-is-hd\/history-and-genetics-of-huntingtons-disease\/who-is-at-risk\/#:\u223c:text=Every%20child%20of%20a%20parent,it%20on%20to%20their%20children."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0640","doi-asserted-by":"crossref","first-page":"91","DOI":"10.31887\/DCNS.2016.18.1\/pnopoulos","article-title":"Huntington disease: a single-gene degenerative disorder of the striatum","volume":"18","author":"Nopoulos","year":"2016","journal-title":"Dialogues Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.bcp.2024.116174_b0645","first-page":"e28484","article-title":"Huntington's disease: a clinical review","volume":"14","author":"Andhale","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.bcp.2024.116174_b0650","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","article-title":"Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities","volume":"16","author":"Tabrizi","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116174_b0655","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JHD-220538","article-title":"Mutant huntingtin protein Interaction map implicates dysregulation of multiple Cellular pathways in neurodegeneration of Huntington's disease","volume":"11","author":"Podvin","year":"2022","journal-title":"J Huntingtons Dis"},{"issue":"2","key":"10.1016\/j.bcp.2024.116174_b0660","first-page":"395","article-title":"Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex","volume":"26","author":"Maiuri","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.bcp.2024.116174_b0665","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-004-0957-5","article-title":"Expression pattern of apoptosis-related markers in Huntington's disease","volume":"109","author":"Vis","year":"2005","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.bcp.2024.116174_b0670","doi-asserted-by":"crossref","first-page":"e0134482","DOI":"10.1371\/journal.pone.0134482","article-title":"PARP-1 inhibition is neuroprotective in the R6\/2 mouse model of Huntington's disease","volume":"10","author":"Cardinale","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116174_b0675","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnana.2017.00061","article-title":"Selective Sparing of striatal interneurons after poly (ADP-ribose) Polymerase 1 inhibition in the R6\/2 mouse model of Huntington's disease","volume":"11","author":"Paldino","year":"2017","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.bcp.2024.116174_b0680","doi-asserted-by":"crossref","unstructured":"T. Maiuri, C.B. Bazan, R.J. Harding, N. Begeja, T.-I. Kam, L.M. Byrne, F.B. Rodrigues, M.M. Warner, K. Neuman, M. Mansoor, M. Badiee, M. Dasovich, A.K.L. Leung, S.N. Andres, E.J. Wild, T.M. Dawson, V.L. Dawson, C.H. Arrowsmith, R. Truant, Poly ADP-Ribose Signaling is Dysregulated in Huntington\u2019s Disease Patients, bioRxiv (2022) 2022.11.23.517669.","DOI":"10.1101\/2022.11.23.517669"},{"issue":"3","key":"10.1016\/j.bcp.2024.116174_b0685","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1917030","article-title":"Acute ischemic stroke","volume":"383","author":"Powers","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.bcp.2024.116174_b0690","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"American Heart Association Council on, C. prevention statistics, S. stroke statistics, Heart disease and stroke Statistics-2018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2024.116174_b0695","article-title":"The next step in the treatment of stroke","volume":"11","author":"Matei","year":"2020","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116174_b0700","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1523\/JNEUROSCI.13-06-02651.1993","article-title":"Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures","volume":"13","author":"Dawson","year":"1993","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"issue":"14","key":"10.1016\/j.bcp.2024.116174_b0705","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1073\/pnas.88.14.6368","article-title":"Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures","volume":"88","author":"Dawson","year":"1991","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.bcp.2024.116174_b0710","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/01.STR.28.6.1283","article-title":"Nitric oxide synthase in models of focal ischemia","volume":"28","author":"Samdani","year":"1997","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0715","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1021\/acs.jmedchem.2c01803","article-title":"Development of a potent cyclic peptide inhibitor of the nNOS\/PSD-95 Interaction","volume":"66","author":"Balboa","year":"2023","journal-title":"J. Med. Chem."},{"issue":"5421","key":"10.1016\/j.bcp.2024.116174_b0720","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1126\/science.284.5421.1845","article-title":"Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein","volume":"284","author":"Sattler","year":"1999","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bcp.2024.116174_b0725","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/jcbfm.2015.16","article-title":"Tat-NR2B9c prevents excitotoxic neuronal superoxide production","volume":"35","author":"Chen","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"6","key":"10.1016\/j.bcp.2024.116174_b0730","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1523\/JNEUROSCI.18-06-02040.1998","article-title":"Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity","volume":"18","author":"Gonzalez-Zulueta","year":"1998","journal-title":"The Journal of Neuroscience: the Official Journal of the Society for Neuroscience"},{"issue":"11","key":"10.1016\/j.bcp.2024.116174_b0735","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00004647-199711000-00002","article-title":"Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase","volume":"17","author":"Endres","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.bcp.2024.116174_b0740","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/jcbfm.1993.48","article-title":"Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion","volume":"13","author":"Malinski","year":"1993","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"5147","key":"10.1016\/j.bcp.2024.116174_b0745","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.8080500","article-title":"Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity","volume":"263","author":"Zhang","year":"1994","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.bcp.2024.116174_b0750","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nm1097-1089","article-title":"Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia","volume":"3","author":"Eliasson","year":"1997","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0755","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/jnc.15464","article-title":"Emerging role of PARP-1 and PARthanatos in ischemic stroke","volume":"160","author":"Liu","year":"2022","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2024.116174_b0760","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fncel.2020.00077","article-title":"Delayed PARP-1 inhibition alleviates post-stroke inflammation in male versus female mice: differences and Similarities","volume":"14","author":"Chen","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0765","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41419-023-05581-x","article-title":"Crocetin antagonizes parthanatos in ischemic stroke via inhibiting NOX2 and preserving mitochondrial hexokinase-I","volume":"14","author":"Wu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bcp.2024.116174_b0770","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1101\/gad.291518.116","article-title":"PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes","volume":"31","author":"Gupte","year":"2017","journal-title":"Genes Dev."},{"issue":"7800","key":"10.1016\/j.bcp.2024.116174_b0775","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41586-020-2013-6","article-title":"HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation","volume":"579","author":"Suskiewicz","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2024.116174_b0780","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41594-023-00977-x","article-title":"HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage","volume":"30","author":"Smith","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116174_b0785","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.molcel.2016.03.008","article-title":"HPF1\/C4orf27 is a PARP-1-Interacting protein that regulates PARP-1 ADP-ribosylation activity","volume":"62","author":"Gibbs-Seymour","year":"2016","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.bcp.2024.116174_b0790","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1042\/BST20220749","article-title":"The function and regulation of ADP-ribosylation in the DNA damage response","volume":"51","author":"Duma","year":"2023","journal-title":"Biochem. Soc. Trans."},{"issue":"9","key":"10.1016\/j.bcp.2024.116174_b0795","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.tibs.2021.01.014","article-title":"Rapid detection and signaling of DNA damage by PARP-1","volume":"46","author":"Pandey","year":"2021","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.bcp.2024.116174_b0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2019.102651","article-title":"PARP-1 and its associated nucleases in DNA damage response","volume":"81","author":"Wang","year":"2019","journal-title":"DNA Repair (amst)"},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0805","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/10409238.2017.1394265","article-title":"Specificity of reversible ADP-ribosylation and regulation of cellular processes","volume":"53","author":"Crawford","year":"2018","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.bcp.2024.116174_b0810","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1476-4598-11-48","article-title":"Silencing of apoptosis-inducing factor and poly(ADP-ribose) glycohydrolase reveals novel roles in breast cancer cell death after chemotherapy","volume":"11","author":"Feng","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2024.116174_b0815","doi-asserted-by":"crossref","unstructured":"D.W. Koh, A.M. Lawler, M.F. Poitras, M. Sasaki, S. Wattler, M.C. Nehls, T. Stoger, G.G. Poirier, V.L. Dawson, T.M. Dawson, Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality, Proceedings of the National Academy of Sciences of the United States of America 101(51) (2004) 17699-704.","DOI":"10.1073\/pnas.0406182101"},{"key":"10.1016\/j.bcp.2024.116174_b0820","doi-asserted-by":"crossref","unstructured":"M. Mashimo, J. Kato, J. Moss, ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress, Proceedings of the National Academy of Sciences of the United States of America 110(47) (2013) 18964-9.","DOI":"10.1073\/pnas.1312783110"},{"issue":"7","key":"10.1016\/j.bcp.2024.116174_b0825","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41584-019-0238-2","article-title":"The immunobiology of MIF: function, genetics and prospects for precision medicine","volume":"15","author":"Kang","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"13","key":"10.1016\/j.bcp.2024.116174_b0830","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1021\/acs.jmedchem.3c00397","article-title":"Allosteric inhibitors of macrophage migration inhibitory factor (MIF) interfere with apoptosis-inducing factor (AIF) co-localization to prevent Parthanatos","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116174_b0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102078","article-title":"Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: past, present, and future","volume":"91","author":"Hu","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bcp.2024.116174_b0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118975","article-title":"Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases","volume":"267","author":"Thapa","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0845","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1038\/s41467-022-34148-1","article-title":"Structural dynamics of DNA strand break sensing by PARP-1 at a single-molecule level","volume":"13","author":"Sefer","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0850","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0022-2836(89)90302-1","article-title":"Zinc-binding domain of poly(ADP-ribose)polymerase participates in the recognition of single strand breaks on DNA","volume":"210","author":"Menissier-de Murcia","year":"1989","journal-title":"J. Mol. Biol."},{"issue":"35","key":"10.1016\/j.bcp.2024.116174_b0855","doi-asserted-by":"crossref","first-page":"21907","DOI":"10.1016\/S0021-9258(18)45824-3","article-title":"The zinc fingers of human poly(ADP-ribose) polymerase are differentially required for the recognition of DNA breaks and nicks and the consequent enzyme activation. Other structures recognize intact DNA","volume":"265","author":"Ikejima","year":"1990","journal-title":"J Biol Chem"},{"issue":"6422","key":"10.1016\/j.bcp.2024.116174_b0860","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/362709a0","article-title":"Instability and decay of the primary structure of DNA","volume":"362","author":"Lindahl","year":"1993","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.bcp.2024.116174_b0865","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.molcel.2022.06.011","article-title":"Captured snapshots of PARP1 in the active state reveal the mechanics of PARP1 allostery","volume":"82","author":"Rouleau-Turcotte","year":"2022","journal-title":"Mol. Cell"},{"issue":"24","key":"10.1016\/j.bcp.2024.116174_b0870","doi-asserted-by":"crossref","first-page":"16464","DOI":"10.1021\/acs.jmedchem.3c00865","article-title":"Advances in development of selective antitumor inhibitors that Target PARP-1","volume":"66","author":"Liu","year":"2023","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2024.116174_b0875","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105112","article-title":"A structural perspective on PARP1, PARP2, and PARP3 in DNA damage repair and nucleosome remodelling","volume":"22","author":"van Beek","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6486","key":"10.1016\/j.bcp.2024.116174_b0880","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax6367","article-title":"Structural basis for allosteric PARP-1 retention on DNA breaks","volume":"368","author":"Zandarashvili","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0885","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.sbi.2013.01.003","article-title":"PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis","volume":"23","author":"Langelier","year":"2013","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"6082","key":"10.1016\/j.bcp.2024.116174_b0890","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.1216338","article-title":"Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP-1","volume":"336","author":"Langelier","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0895","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41467-018-03234-8","article-title":"NAD(+) analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains","volume":"9","author":"Langelier","year":"2018","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.bcp.2024.116174_b0900","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1016\/j.molcel.2021.11.014","article-title":"The BRCT domain of PARP1 binds intact DNA and mediates intrastrand transfer","volume":"81","author":"Rudolph","year":"2021","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0905","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00018-021-04109-w","article-title":"The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis","volume":"79","author":"Liu","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2024.116174_b0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105299","article-title":"Parthanatos and its associated components: promising therapeutic targets for cancer","volume":"163","author":"Zhou","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"10106","key":"10.1016\/j.bcp.2024.116174_b0915","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(17)32418-2","article-title":"PARP inhibitors for targeted treatment in ovarian cancer","volume":"390","author":"Dizon","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2024.116174_b0920","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016573","article-title":"Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1","volume":"296","author":"Ryan","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116174_b0925","doi-asserted-by":"crossref","first-page":"1133472","DOI":"10.3389\/fcell.2023.1133472","article-title":"Targeting the BRCA1\/2 deficient cancer with PARP inhibitors: clinical outcomes and mechanistic insights","volume":"11","author":"Ragupathi","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116174_b0930","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.chembiol.2021.02.004","article-title":"Avoid the trap: Targeting PARP1 beyond human malignancy","volume":"28","author":"Kim","year":"2021","journal-title":"Cell Chem. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116174_b0935","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.expneurol.2009.03.020","article-title":"Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos","volume":"218","author":"Wang","year":"2009","journal-title":"Exp. Neurol."},{"issue":"6718","key":"10.1016\/j.bcp.2024.116174_b0940","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/17135","article-title":"Molecular characterization of mitochondrial apoptosis-inducing factor","volume":"397","author":"Susin","year":"1999","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.bcp.2024.116174_b0945","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1038\/sj.emboj.7600461","article-title":"AIF deficiency compromises oxidative phosphorylation","volume":"23","author":"Vahsen","year":"2004","journal-title":"EMBO J."},{"issue":"17","key":"10.1016\/j.bcp.2024.116174_b0950","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1038\/sj.emboj.7601276","article-title":"Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis","volume":"25","author":"Cheung","year":"2006","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bcp.2024.116174_b0955","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.tcb.2006.03.008","article-title":"Apoptosis-inducing factor: vital and lethal","volume":"16","author":"Modjtahedi","year":"2006","journal-title":"Trends Cell Biol."},{"issue":"12","key":"10.1016\/j.bcp.2024.116174_b0960","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1089\/ars.2010.3445","article-title":"Apoptosis-inducing factor: structure, function, and redox regulation","volume":"14","author":"Sevrioukova","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.bcp.2024.116174_b0965","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/iub.2390","article-title":"The apoptosis-inducing factor family: moonlighting proteins in the crosstalk between mitochondria and nuclei","volume":"73","author":"Novo","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bcp.2024.116174_b0970","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ebiom.2018.03.016","article-title":"Apoptosis-inducing factor (AIF) in physiology and disease: the tale of a repented natural born killer","volume":"30","author":"Bano","year":"2018","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.bcp.2024.116174_b0975","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nsb793","article-title":"The crystal structure of the mouse apoptosis-inducing factor AIF","volume":"9","author":"Mate","year":"2002","journal-title":"Nat. Struct. Biol."},{"issue":"9","key":"10.1016\/j.bcp.2024.116174_b0980","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/nsb836","article-title":"DNA binding is required for the apoptogenic action of apoptosis inducing factor","volume":"9","author":"Ye","year":"2002","journal-title":"Nat. Struct. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b0985","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s41598-017-01337-8","article-title":"Structural and biochemical insights of CypA and AIF interaction","volume":"7","author":"Farina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116174_b0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108088","article-title":"Inhibiting the interaction between apoptosis-inducing factor and cyclophilin a prevents brain injury in neonatal mice after hypoxia-ischemia","volume":"171","author":"Rodriguez","year":"2020","journal-title":"Neuropharmacology"},{"issue":"43","key":"10.1016\/j.bcp.2024.116174_b0995","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1038\/sj.onc.1206794","article-title":"Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor","volume":"22","author":"Gurbuxani","year":"2003","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bcp.2024.116174_b1000","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ncb0901-839","article-title":"Heat-shock protein 70 antagonizes apoptosis-inducing factor","volume":"3","author":"Ravagnan","year":"2001","journal-title":"Nat. Cell Biol."},{"issue":"15","key":"10.1016\/j.bcp.2024.116174_b1005","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1021\/acs.jmedchem.1c00777","article-title":"Design, optimization, and structural Characterization of an apoptosis-inducing factor peptide Targeting human cyclophilin a to inhibit apoptosis inducing factor-mediated cell death","volume":"64","author":"Russo","year":"2021","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bcp.2024.116174_b1010","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1073\/pnas.93.15.7849","article-title":"An essential regulatory role for macrophage migration inhibitory factor in T-cell activation","volume":"93","author":"Bacher","year":"1996","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.bcp.2024.116174_b1015","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: a regulator of innate immunity","volume":"3","author":"Calandra","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b1020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cyto.2012.03.014","article-title":"D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family","volume":"59","author":"Merk","year":"2012","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.bcp.2024.116174_b1025","first-page":"415","article-title":"Crystal structure of macrophage migration inhibitory factor (MIF), a glucocorticoid-induced regulator of cytokine production, reveals a unique architecture","volume":"108","author":"Lolis","year":"1996","journal-title":"P Assoc Am Physician"},{"issue":"12","key":"10.1016\/j.bcp.2024.116174_b1030","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1042\/BCJ20200068","article-title":"Structural and functional insights into macrophage migration inhibitory factor from oncomelania hupensis, the intermediate host of Schistosoma japonicum","volume":"477","author":"Su","year":"2020","journal-title":"Biochem. J"},{"issue":"20","key":"10.1016\/j.bcp.2024.116174_b1035","doi-asserted-by":"crossref","first-page":"21406","DOI":"10.1074\/jbc.M311416200","article-title":"Xenopus laevis macrophage migration inhibitory factor is essential for axis formation and neural development","volume":"279","author":"Suzuki","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.bcp.2024.116174_b1040","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1021\/bi9904048","article-title":"Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 a resolution: implications for enzymatic catalysis and inhibition","volume":"38","author":"Taylor","year":"1999","journal-title":"Biochemistry"},{"issue":"22","key":"10.1016\/j.bcp.2024.116174_b1045","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1021\/bi990306m","article-title":"Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity","volume":"38","author":"Lubetsky","year":"1999","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.bcp.2024.116174_b1050","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.drudis.2018.06.017","article-title":"Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders","volume":"23","author":"Kok","year":"2018","journal-title":"Drug Discov. Today"},{"issue":"28","key":"10.1016\/j.bcp.2024.116174_b1055","doi-asserted-by":"crossref","first-page":"24976","DOI":"10.1074\/jbc.M203220200","article-title":"The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents","volume":"277","author":"Lubetsky","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116174_b1060","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1021\/jm801100v","article-title":"Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening","volume":"52","author":"Cournia","year":"2009","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bcp.2024.116174_b1065","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/cmdc.201800158","article-title":"Optimization of pyrazoles as phenol surrogates to yield potent inhibitors of macrophage migration inhibitory factor","volume":"13","author":"Trivedi-Parmar","year":"2018","journal-title":"ChemMedChem"},{"issue":"36","key":"10.1016\/j.bcp.2024.116174_b1070","doi-asserted-by":"crossref","first-page":"30653","DOI":"10.1074\/jbc.M112.385583","article-title":"A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF)","volume":"287","author":"Bai","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"51","key":"10.1016\/j.bcp.2024.116174_b1075","doi-asserted-by":"crossref","first-page":"26502","DOI":"10.1074\/jbc.M116.743328","article-title":"Identification of iguratimod as an inhibitor of macrophage migration inhibitory factor (MIF) with steroid-sparing potential","volume":"291","author":"Bloom","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.bcp.2024.116174_b1080","doi-asserted-by":"crossref","first-page":"11313","DOI":"10.1073\/pnas.1002716107","article-title":"Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast","volume":"107","author":"Cho","year":"2010","journal-title":"PNAS"},{"issue":"35","key":"10.1016\/j.bcp.2024.116174_b1085","doi-asserted-by":"crossref","first-page":"10138","DOI":"10.1021\/acs.jafc.1c03367","article-title":"Identification and structure-activity relationships of Dietary flavonoids as human macrophage migration inhibitory factor (MIF) inhibitors","volume":"69","author":"Yang","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bcp.2024.116174_b1090","article-title":"Repurposing old drugs as novel inhibitors of human MIF from structural and functional analysis","volume":"128445","author":"Yang","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"29","key":"10.1016\/j.bcp.2024.116174_b1095","doi-asserted-by":"crossref","first-page":"24844","DOI":"10.1074\/jbc.M112.341321","article-title":"Novel anti-inflammatory activity of epoxyazadiradione against macrophage migration inhibitory factor: inhibition of tautomerase and proinflammatory activities of macrophage migration inhibitory factor","volume":"287","author":"Alam","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116174_b1100","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1038\/s41467-021-23264-z","article-title":"MIF is a 3' flap nuclease that facilitates DNA replication and promotes tumor growth","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2024.116174_b1105","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29748","article-title":"Blocking the self-destruct program of dopamine neurons through macrophage migration inhibitory factor nuclease inhibition","author":"Patel","year":"2024","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.bcp.2024.116174_b1110","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41557-018-0187-4","article-title":"Rapamycin-inspired macrocycles with new target specificity","volume":"11","author":"Guo","year":"2019","journal-title":"Nat. Chem."},{"issue":"11","key":"10.1016\/j.bcp.2024.116174_b1115","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2217\/rme-2020-0130","article-title":"Systematic investigation and comparison of US FDA-approved immunosuppressive drugs FK506, cyclosporine and rapamycin for neuromuscular regeneration following chronic nerve compression injury","volume":"16","author":"Degrugillier","year":"2021","journal-title":"Regen. Med."},{"key":"10.1016\/j.bcp.2024.116174_b1120","unstructured":"P.b. Schrodinger, 2024. https:\/\/pymol.org\/2\/."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:16:15Z","timestamp":1731456975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224001576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":224,"alternative-id":["S0006295224001576"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116174","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116174"}}